IPP Bureau
UBC acquires Examoto
By IPP Bureau - August 02, 2022
With this acquisition, UBC provides the most comprehensive REMS services and innovative risk mitigation solutions for the biopharmaceutical industry
Ayush Minister Sonowal inaugurates Ayush Building Complex in Navi Mumbai
By IPP Bureau - August 01, 2022
Steps afoot to make RRIH & RRIUM as a Centres of Excellence for Allergic Disorder and for Regimental Therapy respectively
Casper Pharma completed USFDA pre-approval inspection
By IPP Bureau - July 31, 2022
The audit is part of the agency's inspection for three product applications filed and slated to be manufactured at this site.
Shilpa Medicare's Unit III, Advanced Analytical Characterization Laboratory clears US FDA remote record review
By IPP Bureau - July 31, 2022
The facility is designed with advanced analytical equipment to provide testing services such as In-vitro Permeation testing
Cipla posts Q1FY23 consolidated PAT at Rs. 686.40 Cr
By IPP Bureau - July 31, 2022
he company has reported total income of Rs. 5478.62 crores during the period ended June 30, 2022.
Torrent Pharmaceuticals posts Q1FY23 consolidated PAT Rs. 354 Cr
By IPP Bureau - July 31, 2022
Torrent Pharmaceuticals has reported total income of Rs. 2377 crores during the period ended June 30, 2022.
Cariflex breaks ground on world's largest polyisoprene latex plant in Singapore
By IPP Bureau - July 29, 2022
Driven by a strong commitment to better serve its global customers in medical and consumer products, this investment represents the largest capacity expansion in Cariflex’s existing accomplishments
Alniche Lifesciences celebrates 15 anniversary
By IPP Bureau - July 29, 2022
The company is focused on therapies such as skinceuticals, gastroenterology, neuropsychiatry, cardiac diabetes care etc.
GMM Pfaudler Q1FY23 consolidated PAT surges to Rs. 44.51 Cr
By IPP Bureau - July 29, 2022
GMM Pfaudler has reported total income of Rs. 767.73 crores during the period ended June 30, 2022
Biocon Q1FY23 consolidated PAT falls QoQ at Rs. 144.4 Cr
By IPP Bureau - July 28, 2022
Biocon has reported total income of Rs. 2217.4 crores during the period ended June 30, 2022.
Novartis India Q1FY23 PAT jumps to Rs. 52.38 Cr
By IPP Bureau - July 28, 2022
Novartis India has reported total income of Rs. 147.44 crores during the period ended June 30, 2022.
Dr. Reddy's launches Bortezomib for Injection, 3.5 mg Single-Dose Vial in the U.S. Market
By IPP Bureau - July 28, 2022
The Velcade Brand and generic had U.S. sales of approximately $1.2 billion MAT for the most recent twelve months ending in May 2022
India has achieved replacement level fertility: Minister Pawar
By IPP Bureau - July 28, 2022
Pawar also unveiled the India Family Planning 2030 vision document and launched the Medical Eligibility Criteria (MEC) Wheel Application, E-Module of Family Planning Logistics Management System (FPLMIS) and Digital Archive on Family Planning under the category of Digital Intervention.
Velocity Clinical Research begins European expansion with German site acquisition
By IPP Bureau - July 28, 2022
Biopharma and CROs to benefit from simplified access to global research sites
